tiprankstipranks
Trending News
More News >
Medifast Inc (MED)
NYSE:MED
US Market

Medifast (MED) Stock Forecast & Price Target

Compare
1,237 Followers
See the Price Targets and Ratings of:

MED Financial Forecast

MED Earnings Forecast

Next quarter’s earnings estimate for MED is -$0.22 with a range of -$0.22 to -$0.22. The previous quarter’s EPS was -$0.03. MED beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.45% of the time in the same period. In the last calendar year MED has Outperformed its overall industry.
Next quarter’s earnings estimate for MED is -$0.22 with a range of -$0.22 to -$0.22. The previous quarter’s EPS was -$0.03. MED beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.45% of the time in the same period. In the last calendar year MED has Outperformed its overall industry.

MED Sales Forecast

Next quarter’s sales forecast for MED is $96.10M with a range of $96.10M to $96.10M. The previous quarter’s sales results were $115.73M. MED beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.57% of the time in the same period. In the last calendar year MED has Outperformed its overall industry.
Next quarter’s sales forecast for MED is $96.10M with a range of $96.10M to $96.10M. The previous quarter’s sales results were $115.73M. MED beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.57% of the time in the same period. In the last calendar year MED has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MED
TipRanks AITipRanks
Not Ranked
TipRanks
$14
Hold
6.38%
Upside
Reiterated
06/13/25
Medifast's overall score reflects significant financial and valuation challenges, with declining revenues and negative profitability being the most impactful factors. While a strong balance sheet and some positive operational highlights from the earnings call provide stability, the technical outlook and valuation concerns keep the score subdued.
D.A. Davidson Analyst forecast on MED
Linda Bolton WeiserD.A. Davidson
D.A. Davidson
$17$16.5
Hold
25.38%
Upside
Reiterated
02/20/25
Medifast (MED) PT Lowered to $16.50 at DA DavidsonDA Davidson analyst Linda Bolton Weiser lowered the price target on Medifast (NYSE: MED) to $16.50 (from $17.00) while maintaining a Neutral rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MED
TipRanks AITipRanks
Not Ranked
TipRanks
$14
Hold
6.38%
Upside
Reiterated
06/13/25
Medifast's overall score reflects significant financial and valuation challenges, with declining revenues and negative profitability being the most impactful factors. While a strong balance sheet and some positive operational highlights from the earnings call provide stability, the technical outlook and valuation concerns keep the score subdued.
D.A. Davidson Analyst forecast on MED
Linda Bolton WeiserD.A. Davidson
D.A. Davidson
$17$16.5
Hold
25.38%
Upside
Reiterated
02/20/25
Medifast (MED) PT Lowered to $16.50 at DA DavidsonDA Davidson analyst Linda Bolton Weiser lowered the price target on Medifast (NYSE: MED) to $16.50 (from $17.00) while maintaining a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

MED Analyst Recommendation Trends

Rating
Jun 24
Jul 24
Aug 24
Nov 24
Feb 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
5
2
0
1
2
Sell
1
2
3
2
1
Strong Sell
0
0
0
0
0
total
6
4
3
3
3
In the current month, MED has received 0 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. MED average Analyst price target in the past 3 months is 16.50.
Each month's total comprises the sum of three months' worth of ratings.

MED Stock Forecast FAQ

What is MED’s average 12-month price target, according to analysts?
Based on analyst ratings, Medifast Inc’s 12-month average price target is 16.50.
    What is MED’s upside potential, based on the analysts’ average price target?
    Medifast Inc has 25.38% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MED a Buy, Sell or Hold?
          Medifast Inc has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Medifast Inc’s price target?
            The average price target for Medifast Inc is 16.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $16.50 ,the lowest forecast is $16.50. The average price target represents 25.38% Increase from the current price of $13.16.
              What do analysts say about Medifast Inc?
              Medifast Inc’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of MED?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis